Image Place holder

Aliyah Baluch, MD, MSc

Specialty: Infectious Diseases
Program: Infectious Diseases

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)


Locations: Moffitt Cancer Center
Overview

Dr. Aliyah Baluch is the Bone Marrow Transplant Infectious Diseases (BMT ID) attending.  She has clinic in the BMT Clinic half a day per week.  Her overall interests are infections in immunosuppressed patients (BMT and solid organ transplant recipients) with a focus on microbiology with antimicrobial stewardship.  She coordinates monthly microbiology rounds between pathologists, internal medicine, infectious disease physicians and rotating medical students.  As an educator, Dr. Baluch also gives lectures at Moffitt and outside facilities on various subjects pertinent to Transplant Infectious Diseases.  On a regular basis, medical students, nurse practitioner and physician assistant students rotate with Dr. Baluch.  Dr. Aliyah Baluch participates on multiple Moffitt committees as the ID liaison.  Dr. Baluch also continues to be abstract and journal reviewer for many national committees and peer-reviewed publications.   In her free time, Dr. Baluch also volunteers via the Moffitt volunteer group, STARS.

Education & Training

Board Certification:

  • Infectious Disease
  • Internal Medicine

Fellowship:

  • University of South Florida - Infectious and Tropical Medicine
  • University of Alberta - Transplant Infectious Diseases

Residency:

  • University of South Florida - Internal Medicine
  • H. Lee Moffitt Cancer Center - Internal Medicine

Medical School:

  • University of South Florida - MD
Awards
Start Year: 2013 End Year: 2013 Nick Porter Award for “Spirit of Moffitt”, Sponsor: Moffitt Cancer Center
Start Year: 2012 End Year: 2012 Young Investigator Award , Sponsor: American Transplant Congress
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Logue JM, Zucchetti E, Bachmeier CA, Krivenko GS, Larson V, Ninh D, Grillo G, Cao B, Kim J, Chavez JC, Baluch A, Khimani F, Lazaryan A, Nishihori T, Liu HD, Pinilla-Ibarz J, Shah BD, Faramand R, Coghill AE, Davila ML, Dholaria BR, Jain MD, Locke FL. Immune reconstitution and associated infections following axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma. Haematologica. 2020 Apr. Pubmedid: 32327504.
  • Baluch A, Pasikhova Y, Snyder M. Successful management of Mycobacterium haemophilum lower extremity cutaneous infection in a matched-unrelated donor stem cell transplant recipient. Transpl Infect Dis. 2017 Feb.19(1). Pubmedid: 27775824.
  • Snyder M, Pasikhova Y, Baluch A. Early Antimicrobial De-escalation and Stewardship in Adult Hematopoietic Stem Cell Transplantation Recipients: Retrospective Review. Open Forum Infect Dis. 2017 Dec.4(4):ofx226. Pubmedid: 29255727. Pmcid: PMC5726466.
  • Pasikhova Y, Ludlow S, Baluch A. Fever in Patients With Cancer. Cancer Control. 2017 Apr.24(2):193-197. Pubmedid: 28441374.
  • Shannon K, Pasikhova Y, Ibekweh Q, Ludlow S, Baluch A. Nocardiosis following hematopoietic stem cell transplantation. Transpl Infect Dis. 2016 Apr.18(2):169-175. Pubmedid: 26809666.
  • Egli A, Humar A, Widmer LA, Lisboa LF, Santer DM, Mueller T, Stelling J, Baluch A, O'Shea D, Houghton M, Kumar D. Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination. J Infect Dis. 2015 Jul.212(1):137-146. Pubmedid: 25589334.
  • Fernández-Ruiz M, Humar A, Baluch A, Keshwani S, Husain S, Kumar D. Baseline serum interleukin-6 to interleukin-2 ratio is associated with the response to seasonal trivalent influenza vaccine in solid organ transplant recipients. Vaccine. 2015 Dec.33(51):7176-7182. Pubmedid: 26555352.
  • Egli A, Santer DM, O'Shea D, Barakat K, Syedbasha M, Vollmer M, Baluch A, Bhat R, Groenendyk J, Joyce MA, Lisboa LF, Thomas BS, Battegay M, Khanna N, Mueller T, Tyrrell DL, Houghton M, Humar A, Kumar D. IL-28B is a key regulator of B- and T-cell vaccine responses against influenza. PLoS Pathog. 2014 Dec.10(12):e1004556. Pubmedid: 25503988. Pmcid: PMC4263767.
  • Silva M, Humar A, Shapiro AM, Senior P, Hoschler K, Baluch A, Wilson LE, Kumar D. Humoral immune response following seasonal influenza vaccine in islet transplant recipients. Cell Transplant. 2013 Sep.22(3):469-476. Pubmedid: 23006439.
  • Egli A, Silva M, O'Shea D, Wilson LE, Baluch A, Lisboa LF, Hidalgo LG, Kumar D, Humar A. An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients. PLoS One. 2013 Mar.7(11):e43937. Pubmedid: 23071829. Pmcid: PMC3469568.
  • Alrabaa SF, Nguyen P, Sanderson R, Baluch A, Sandin RL, Kelker D, Karlapalem C, Thompson P, Sams K, Martin S, Montero J, Greene JN. Early identification and control of carbapenemase-producing Klebsiella pneumoniae, originating from contaminated endoscopic equipment. Am J Infect Control. 2013 Jun.41(6):562-564. Pubmedid: 23171594.
  • Baluch A, Pasikhova Y. Influenza vaccination in oncology patients. Curr Infect Dis Rep. 2013 Dec.15(6):486-490. Pubmedid: 24258350.
  • Baluch A, Humar A, Eurich D, Egli A, Liacini A, Hoschler K, Campbell P, Berka N, Urschel S, Wilson L, Kumar D. Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients. Am J Transplant. 2013 Apr.13(4):1026-1033. Pubmedid: 23406320.
  • Baluch A, Humar A, Egli A, Gubbay J, Lisboa L, Wilson L, Kumar D. Long term immune responses to pandemic influenza A/H1N1 infection in solid organ transplant recipients. PLoS One. 2012 Aug.6(12):e28627. Pubmedid: 22194870. Pmcid: PMC3237471.
  • Baluch A. State of the Globe: The Rippling Effect of Multidrug-Resistant Gram-negative Infections. J Glob Infect Dis. 7(4):125-126. Pubmedid: 26752866. Pmcid: PMC4693302.

Patient Comments
Overall Satisfaction
5

5 patients rated this provider

The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.

Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Learn more about our patient satisfaction survey

Comments ()

Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.

We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.

Not all providers will have a star rating or comments. In order to ensure accuracy of our ratings, we only display ratings for providers who have a minimum of 30 completed from the previous 12 months.

Learn more about our patient comments

Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:

  • The provider has not yet received the minimum number of patient satisfaction surveys to be eligible for display. We require a minimum of 30 surveys before we post results to ensure that the rating is statistically reliable and a true reflection of patient satisfaction.
  • He or she may be a researcher or other type of provider that does not see patients.
  • The provider practices in a specialty or office that does not use the specified surveys currently used for these ratings.
Learn more about our patient satisfaction survey, ratings and comments